Refractec Viewpoint Hyperopia Approval Limited To Temporary Treatment
This article was originally published in The Gray Sheet
Executive Summary
Refractec is positioning its Viewpoint CK conductive keratoplasty system as a potentially favorable alternative to LASIK for hyperopia (farsightedness) despite FDA approval limiting the product to "temporary" treatment